Alnylam Pharmaceuticals (ALNY) Construction in Progress (2012 - 2018)

Alnylam Pharmaceuticals' Construction in Progress history runs 7 years deep, the most recent figure standing at $261.0 million for Q4 2018.

• Quarterly Construction in Progress rose 95.27% year-over-year to $261.0 million in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $261.0 million (up 95.27% YoY) and the FY2018 annual result came in at $261.0 million, up 95.27% from the prior year.
• Construction in Progress was $261.0 million for Q4 2018 at Alnylam Pharmaceuticals, up from $133.6 million in the prior quarter.
• Across five years, Construction in Progress topped out at $261.0 million in Q4 2018 and bottomed at $1.3 million in Q4 2015.
• A 5-year average of $93.2 million and a median of $68.2 million in 2016 frame the typical range for Construction in Progress.
• Annual changes were most pronounced in 2014 — Construction in Progress jumped 6978.57% — and 2015, when it tumbled 35.17%.
• Alnylam Pharmaceuticals' Construction in Progress stood at $2.0 million in 2014, then tumbled by 35.17% to $1.3 million in 2015, then soared by 5205.99% to $68.2 million in 2016, then jumped by 96.01% to $133.6 million in 2017, then surged by 95.27% to $261.0 million in 2018.
• Business Quant data shows ALNY's Construction in Progress at $261.0 million in Q4 2018, $133.6 million in Q4 2017, and $68.2 million in Q4 2016.